Keywords: semaglutide, GLP-1 receptor agonist, obesity, weight loss therapy, metabolic disorders 1
At 20% loss: Near-normalization of many health markers Dramatic visual transformation Multiple clothing size changes Possible resolution of conditions like sleep apnea, prediabetes Life-changing improvement for most patients Interpreting Your Results If you lose 12% of your body weight and feel disappointed because you hoped for 20%, consider: Youre in the successful majority
The large-scale STEP clinical trials (Semaglutide Treatment Effect in People with Obesity), published in the New England Journal of Medicine and JAMA, did not report increased cold sensitivity as a significant adverse effect
It may be life-threatening and requires emergency medical treatment
As these options become more widely available, women will have more flexibility to choose delivery methods that optimize their treatment experience across all quality-of-life measures, including sexual function
